Valuation: Albert David Limited

Market Cap 3.35B 35.51M 31.14M 28.7M 26.87M 50.39M 51.43M 345M 133M 1.66B 133M 130M 5.74B P/E 2024
8.14x
P/E 2025 26.9x
Enterprise Value 1.04B 10.99M 9.64M 8.88M 8.32M 15.59M 15.92M 107M 41.31M 512M 41.27M 40.37M 1.78B EV / Sales 2024
0.92x
EV / Sales 2025 0.67x
Free-Float
35.96%
Yield 2024
1.07%
Yield 2025 0.62%
1 day-0.24%
1 week-0.37%
Current month+0.01%
1 month-1.06%
3 months+16.30%
6 months-4.89%
Current year-3.81%
1 week 700.05
Extreme 700.05
725.2
1 month 683.5
Extreme 683.5
737.95
Current year 579.9
Extreme 579.9
819.6
1 year 579.9
Extreme 579.9
957.5
3 years 579.9
Extreme 579.9
1,753.95
5 years 479.05
Extreme 479.05
1,753.95
10 years 263
Extreme 263
1,753.95
Manager TitleAgeSince
Chief Executive Officer 52 11/05/2026
Director of Finance/CFO - 30/11/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 29/12/2009
Director/Board Member 68 30/03/2014
Director/Board Member 64 23/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%-0.37% - - 42.24M
-0.62%+1.33%+10.38%+85.95% 47.38B
+0.51%+3.61%+53.73%+106.19% 35.48B
+0.15%+6.53%-4.15%+42.69% 12.33B
+0.19%+2.86%+12.18%+92.99% 11.65B
-0.57%+0.38%+36.72%+124.36% 8.88B
+0.99%+4.52%+21.27%+46.91% 7.21B
+1.58%+5.71%+53.88%-9.81% 6.91B
-1.20%-2.67%+25.90%+228.56% 6.45B
-3.83%-0.76%-35.52%-1.70% 4.94B
Average -0.30%+2.62%+19.38%+79.57% 15.69B
Weighted average by Cap. -0.15%+2.86%+23.60%+87.02%

Financials

2024 2025
Net sales 3.62B 38.42M 33.69M 31.05M 29.07M 54.52M 55.65M 373M 144M 1.79B 144M 141M 6.21B 3.46B 36.65M 32.14M 29.62M 27.73M 52.01M 53.09M 356M 138M 1.71B 138M 135M 5.93B
Net income 754M 8M 7.01M 6.46M 6.05M 11.34M 11.58M 77.67M 30.05M 373M 30.02M 29.37M 1.29B 172M 1.82M 1.6M 1.47M 1.38M 2.59M 2.64M 17.71M 6.85M 85.01M 6.85M 6.7M 295M
Net Debt -2.82B -29.88M -26.2M -24.15M -22.61M -42.4M -43.28M -290M -112M -1.39B -112M -110M -4.83B -2.31B -24.52M -21.5M -19.82M -18.56M -34.8M -35.52M -238M -92.18M -1.14B -92.09M -90.08M -3.96B
Logo Albert David Limited
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Employees
1,805
Date Price Change Volume
25/06/26 ₹708.50 -0.24% 3,117
24/06/26 ₹710.20 -0.98% 1,135
23/06/26 ₹717.20 +0.87% 1,196
22/06/26 ₹711.00 -0.02% 840
19/06/26 ₹711.15 -0.11% 1,513